Dr Rob Marchmont joins Sphere Fluidics as new Commercial Director


07-06-2013

Dr Rob Marchmont, who previously held Senior commercial positions at NanoInk and GE Healthcare and has more than 25 years' experience in the Life Sciences market, has now joined Sphere Fluidics, to help further grow the business, as their new Commercial Director.

Dr Rob Marchmont, who previously held Senior commercial positions at NanoInk and GE Healthcare and has more than 25 years' experience in the Life Sciences market, has now joined Sphere Fluidics, to help further grow the business, as their new Commercial Director.

Dr Marchmont says "I am thrilled to be joining the Sphere Fluidics team and look forward to building the business based on the success already gained and developing new markets for single cell analysis technology".

Dr Frank F. Craig, CEO, said "Rob is a great addition to our team and I look forward to working with him as we accelerate growth of our business".

_________________________________________________

 

Sphere Fluidics is commercialising novel products and R&D services in the area of single cell analysis and characterisation.

Sphere Fluidics Limited